ID

32557

Beskrivning

Study ID: 106837 Clinical Study ID: HZA106837 Study Title: A Long-Term, Randomized, Double-Blind, Parallel Group Study of Fluticasone Furoate/GW642444 Inhalation Powder Once-Daily and Fluticasone Furoate Inhalation Powder Once-Daily in Subjects with Asthma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01086384 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate/vilanterol Trade Name: Relvar Study Indication: Asthma

Nyckelord

  1. 2018-11-06 2018-11-06 -
  2. 2018-12-06 2018-12-06 -
Rättsinnehavare

GSK group of companies

Uppladdad den

6 november 2018

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

A Parallel Group Study of Fluticasone Furoate/Vilanterol in Subjects with Asthma - 106837

Study conclusion

  1. StudyEvent: ODM
    1. Study conclusion
Study conclusion details
Beskrivning

Study conclusion details

Date of subject completion or withdrawal
Beskrivning

Date of subject completion or withdrawal

Datatyp

date

Was the subject withdrawn from the study?
Beskrivning

Was the subject withdrawn from the study?

Datatyp

boolean

If YES, complete primary reason for withdrawal
Beskrivning

If YES, complete primary reason for withdrawal

1. Adverse event
Beskrivning

record details on AE or SAE forms as appropriate)

Datatyp

boolean

2. Lack of efficacy
Beskrivning

Check all that apply. If none, select "No Subreasons"

Datatyp

text

3. Protocol Deviation
Beskrivning

Check all that apply. If none, select "No Subreasons"

Datatyp

text

4. Subject reached protocol defined stopping criteria
Beskrivning

4. Subject reached protocol defined stopping criteria

Datatyp

text

5. Study closed/terminated
Beskrivning

5. Study closed/terminated

Datatyp

boolean

6. Lost to Follow-Up
Beskrivning

6. Lost to Follow-Up

Datatyp

boolean

7. Investigator discretion, specify
Beskrivning

Select this reason if none of the other primary reasons are appropriate

Datatyp

text

8. Withdrew consent, specify
Beskrivning

Select this reason if none of the other primary reasons are appropriate

Datatyp

text

Similar models

Study conclusion

  1. StudyEvent: ODM
    1. Study conclusion
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Study conclusion details
Date of subject completion or withdrawal
Item
Date of subject completion or withdrawal
date
Was the subject withdrawn from the study?
Item
Was the subject withdrawn from the study?
boolean
Item Group
If YES, complete primary reason for withdrawal
1. Adverse event
Item
1. Adverse event
boolean
Item
2. Lack of efficacy
text
Code List
2. Lack of efficacy
CL Item
No subreasons (1)
CL Item
Exacerbation (2)
Item
3. Protocol Deviation
text
Code List
3. Protocol Deviation
CL Item
No subreasons (1)
CL Item
Pregnancy (2)
CL Item
Lack of adherence (3)
CL Item
Prohibited medication use (4)
Item
4. Subject reached protocol defined stopping criteria
text
Code List
4. Subject reached protocol defined stopping criteria
CL Item
Yes (1)
CL Item
No (2)
CL Item
Liver function test abnormality (3)
5. Study closed/terminated
Item
5. Study closed/terminated
boolean
6. Lost to Follow-Up
Item
6. Lost to Follow-Up
boolean
7. Investigator discretion, specify
Item
7. Investigator discretion, specify
text
8. Withdrew consent, specify
Item
8. Withdrew consent, specify
text

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial